Multi-cancer early detection test for people at high risk
Part of Cancer, Genetic & congenital clinical trials.
This study tests a blood-based multi-cancer early detection (MCED) screening test in people with a high risk of cancer due to inherited gene changes or strong family history. The goal is to see if this test can find cancer early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a genetic condition that raises cancer risk, such as a harmful change in a gene like TP53, or a diagnosis like neurofibromatosis.
- You are at least 22 years old (for TP53 gene changes) or 35 or older (for other gene changes).
- Or, you are 45 or older and have a strong family history of cancer, like a close relative with breast, colon, or ovarian cancer before age 50.
- You have not been diagnosed with cancer (except certain early skin cancers) in the last 3 years.
- You have not had a blood-based multi-cancer screening test in the past year.
- You are not currently being evaluated for suspected cancer and have not had preventive surgery to remove organs due to cancer risk (like mastectomy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a blood test that looks for early signs of multiple types of cancer. It is designed for current or former military members who are at least 45 years old and have used VA healthcare. If the test finds something, you would need to be willing to travel to Boston for follow-up.
This study looks at ways to improve the process of diagnosing cancer in people who have signs or symptoms that might be cancer. It may help find cancer earlier and improve care.
This study looks at your personal and family risk for prostate cancer and helps decide who should have extra screening like MRI. It may help you find cancer earlier if you are at higher genetic risk.
This trial uses MRI and endoscopic ultrasound to look for early signs of pancreatic cancer in people who have a high risk due to their genes or family history. Finding it early may lead to better treatment options.
This trial studies whether certain inherited genes increase the risk of myeloid cancers or bone marrow failure. You will provide a DNA sample via a skin biopsy to look for these genetic changes.
This study is testing a blood test that may help find ovarian cancer earlier in people with BRCA1 or BRCA2 gene changes. It involves giving blood samples before and after surgery to remove the ovaries and fallopian tubes, or over several years if you've had a precancerous lesion found.
Hear when a new Cancer Predisposition Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.